P53 is required for nuclear but not mitochondrial DNA damage-induced degeneration.
Ontology highlight
ABSTRACT: While the consequences of nuclear DNA damage have been well studied, the exact consequences of acute and selective mitochondrial DNA (mtDNA) damage are less understood. DNA damaging chemotherapeutic drugs are known to activate p53-dependent apoptosis in response to sustained nuclear DNA damage. While it is recognized that whole-cell exposure to these drugs also damages mtDNA, the specific contribution of mtDNA damage to cellular degeneration is less clear. To examine this, we induced selective mtDNA damage in neuronal axons using microfluidic chambers that allow for the spatial and fluidic isolation of neuronal cell bodies (containing nucleus and mitochondria) from the axons (containing mitochondria). Exposure of the DNA damaging drug cisplatin selectively to only the axons induced mtDNA d
SUBMITTER: Geden MJ
PROVIDER: S-EPMC7817838 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA